A High-Fat Diet Increases Oxidative Renal Injury and Protein Glycation in D-Galactose-Induced Aging Rats and Its Prevention by Korea Red Ginseng
Tóm tắt
Từ khóa
Tài liệu tham khảo
1) Esposito C, Dal Canton A. 2010. Functional changes in the aging kidney. J Nephrol 23 (Suppl 15): S41-45.
3) Cakatay U, Aydin S, Yanar K, Uzun H. 2010. Gender-dependent variations in systemic biomarkers of oxidative protein, DNA, and lipid damage in aged rats. Aging Male 13: 51-58.
4) Kashihara N, Haruna Y, Kondeti VK, Kanwar YS. 2010. Oxidative stress in diabetic nephropathy. Curr Med Chem 17: 4256-4269.
5) Kim S, Hwang SW. 2013. Emerging roles of TRPA1 in sensation of oxidative stress and its implications in defense and danger. Arch Pharm Res 36: 783-791.
6) Choi YJ, Kim HS, Lee J, Chung J, Lee JS, Choi JS, Yoon TR, Kim HK, Chung HY. 2014. Down-regulation of oxidative stress and COX-2 and iNOS expressions by dimethyl lithospermate in aged rat kidney. Arch Pharm Res, Epub ahead of print.
7) Choksi KB, Nuss JE, Boylston WH, Rabek JP, Papaconstantinou J. 2007. Age-related increases in oxidatively damaged proteins of mouse kidney mitochondrial electron transport chain complexes. Free Radic Biol Med 43: 1423-1438.
8) Horie K, Miyata T, Yasuda T, Takeda A, Yasuda Y, Maeda K, Sobue G, Kurokawa K. 1997. Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer’s disease and aged neurons. Biochem Biophys Res Commun 236: 327-332.
9) Hammes HP, Hoerauf H, Alt A, Schleicher E, Clausen JT, Bretzel RG, Laqua H. 1999. N(epsilon)(carboxymethyl)lysin and the AGE receptor RAGE colocalize in age-related macular degeneration. Invest Ophthalmol Vis Sci 40: 1855-1859.
10) Niwa T. 2006. Mass spectrometry for the study of protein glycation in disease. Mass Spectrom Rev 25: 713-723.
11) Dunn JA, McCance DR, Thorpe SR, Lyons TJ, Baynes JW. 1991. Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen. Biochemistry 30: 1205-1210.
12) Schleicher ED, Wagner E, Nerlich AG. 1997. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 99: 457-468.
13) Sell DR, Lane MA, Johnson WA, Masoro EJ, Mock OB, Reiser KM, Fogarty JF, Cutler RG, Ingram DK, Roth GS, Monnier VM. 1996. Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. Proc Natl Acad Sci USA 93: 485-490.
14) Wu DM, Lu J, Zheng YL, Zhou Z, Shan Q, Ma DF. 2008. Purple sweet potato color repairs D-galactose-induced spatial learning and memory impairment by regulating the expression of synaptic proteins. Neurobiol Learn Mem 90: 19-27.
15) Lu J, Wu DM, Zheng YL, Hu B, Zhang ZF, Ye Q, Liu CM, Shan Q, Wang YJ. 2010. Ursolic acid attenuates D-galactose-induced inflammatory response in mouse prefrontal cortex through inhibiting AGEs/RAGE/NF-kappaB pathway activation. Cereb Cortex 20: 2540-2548.
16) Lei M, Hua X, Xiao M, Ding J, Han Q, Hu G. 2008. Impairments of astrocytes are involved in the D-galactose-induced brain aging. Biochem Biophys Res Commun 369: 1082-1087.
17) Lu J, Zheng YL, Wu DM, Luo L, Sun DX, Shan Q. 2007. Ursolic acid ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by D-galactose. Biochem Pharmacol 74: 1078-1090.
18) Fan SH, Zhang ZF, Zheng YL, Lu J, Wu DM, Shan Q, Hu B, Wang YY. 2009. Troxerutin protects the mouse kidney from D-galactose-caused injury through anti-inflammation and anti-oxidation. Int Immunopharmacol 9: 91-96.
19) Zhang ZF, Fan SH, Zheng YL, Lu J, Wu DM, Shan Q, Hu B. 2009. Troxerutin protects the mouse liver against oxidative stress-mediated injury induced by D-galactose. J Agric Food Chem 57: 7731-7736.
20) Hua X, Lei M, Zhang Y, Ding J, Han Q, Hu G, Xiao M. 2007. Long-term D-galactose injection combined with ovariectomy serves as a new rodent model for Alzheimer’s disease. Life Sci 80: 1897-1905.
21) Lai YH, Chen LJ, Cheng JT. 2013. Role of TNF-alpha in renal damage in mice showing hepatic steatosis induced by high fat diet. Horm Metab Res 45: 38-42.
22) Al-Rejaie SS, Abuohashish HM, Alkhamees OA, Aleisa AM, Alroujayee AS. 2012. Gender difference following high cholesterol diet induced renal injury and the protective role of rutin and ascorbic acid combination in Wistar albino rats. Lipids Health Dis 11: 41.
23) Stemmer K, Perez-Tilve D, Ananthakrishnan G, Bort A, Seeley RJ, Tschop MH, Dietrich DR, Pfluger PT. 2012. High-fat-diet-induced obesity causes an inflammatory and tumor-promoting microenvironment in the rat kidney. Dis Model Mech 5: 627-635.
24) Wu D, Ren Z, Pae M, Han SN, Meydani SN. 2013. Diet-induced obesity has a differential effect on adipose tissue and macrophage inflammatory responses of young and old mice. Biofactors 39: 326-333.
25) Kartha GK, Moshal KS, Sen U, Joshua IG, Tyagi N, Steed MM, Tyagi SC. 2008. Renal mitochondrial damage and protein modification in type-2 diabetes. Acta Diabetol 45: 75-81.
26) Ballal K, Wilson CR, Harmancey R, Taegtmeyer H. 2010. Obesogenic high fat western diet induces oxidative stress and apoptosis in rat heart. Mol Cell Biochem 344: 221-230.
27) Du Z, Yang Y, Hu Y, Sun Y, Zhang S, Peng W, Zhong Y, Huang X, Kong W. 2012. A long-term high-fat diet increases oxidative stress, mitochondrial damage and apoptosis in the inner ear of D-galactose-induced aging rats. Hear Res 287: 15-24.
28) Kim P, Park JH, Kwon KJ, Kim KC, Kim HJ, Lee JM, Kim HY, Han SH, Shin CY. 2013. Effects of Korean red ginseng extracts on neural tube defects and impairment of social interaction induced by prenatal exposure to valproic acid. Food Chem Toxicol 51: 288-296.
29) Park HM, Kim SJ, Mun AR, Go HK, Kim GB, Kim SZ, Jang SI, Lee SJ, Kim JS, Kang HS. 2012. Korean red ginseng and its primary ginsenosides inhibit ethanol-induced oxidative injury by suppression of the MAPK pathway in TIB-73 cells. J Ethnopharmacol 141: 1071-1076.
30) Paul S, Shin HS, Kang SC. 2012. Inhibition of inflammations and macrophage activation by ginsenoside-Re isolated from Korean ginseng (Panax ginseng C.A. Meyer). Food Chem Toxicol 50: 1354-1361.
31) Kim ND. 2001. Pharmacologic effect of red ginseng. J Ginseng Res 25: 2-10.
32) Sun BS, Gu LJ, Fang ZM, Wang CY, Wang Z, Lee MR, Li Z, Li JJ, Sung CK. 2009. Simultaneous quantification of 19 ginsenosides in black ginseng developed from Panax ginseng by HPLC-ELSD. J Pharm Biomed Anal 50: 15-22.
33) Quan HY, Kim do Y, Chung SH. 2013. Korean red ginseng extract alleviates advanced glycation end product-mediated renal injury. J Ginseng Res 37: 187-193.
34) Ramesh T, Kim SW, Hwang SY, Sohn SH, Yoo SK, Kim SK. 2012. Panax ginseng reduces oxidative stress and restores antioxidant capacity in aged rats. Nutr Res 32: 718-726.
35) Heo J-H, Lee S-T, Oh MJ, Par H-J, Shim J-Y, Chu K, Kim M. 2011. Improvement of cognitive deficit in Alzheimer’s disease patients by long term treatment with Korean red ginseng. J Ginseng Res 35: 457-461.
36) Hwang S-Y, Sohn S-H, Wee J-J, Yang J-B, Kyung J-S, Kwak Y-S, Kim S-W, Kim S-K. 2010. Panax ginseng improves senile testicular function in rats. J Ginseng Res 34: 327-335.
37) Quan HY, Kim do Y, Chung SH. 2013. Korean red ginseng extract alleviates advanced glycation end product-mediated renal injury. J Ginseng Res 37: 187-193.
38) Doh KC, Lim SW, Piao SG, Jin L, Heo SB, Zheng YF, Bae SK, Hwang GH, Min KI, Chung BH, Yang CW. 2013. Ginseng treatment attenuates chronic cyclosporine nephropathy via reducing oxidative stress in an experimental mouse model. Am J Nephrol 37: 421-433.
39) Lee H, Park D, Yoon M. 2013. Korean red ginseng (Panax ginseng) prevents obesity by inhibiting angiogenesis in high fat diet-induced obese C57BL/6J mice. Food Chem Toxicol 53: 402-408.
40) Kim MS. 2013. Korean red ginseng tonic extends lifespan in D. melanogaster. Biomol Ther 21: 241-245.
41) Park MK, Cho SA, Lee HJ, Lee EJ, Kang JH, Kim YL, Kim HJ, Oh SH, Choi C, Lee H, Kim SY. 2012. Suppression of transglutaminase-2 is involved in anti-inflammatory actions of glucosamine in 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation. Biomol Ther 20: 380-385.
43) Charriaut-Marlangue C, Ben-Ari Y. 1995. A cautionary note on the use of the TUNEL stain to determine apoptosis. Neuroreport 7: 61-64.
44) Ulloa L, Messmer D. 2006. High-mobility group box 1 (HMGB1) proteIn: friend and foe. Cytokine Growth Factor Rev 17: 189-201.
45) Kim J, Sohn E, Kim CS, Jo K, Kim JS. 2011. The role of high-mobility group box-1 protein in the development of diabetic nephropathy. Am J Nephrol 33: 524-529.
46) Hiona A, Leeuwenburgh C. 2008. The role of mitochondrial DNA mutations in aging and sarcopenia: implications for the mitochondrial vicious cycle theory of aging. Exp Gerontol 43: 24-33.
47) Cuzzocrea S, McDonald MC, Filipe HM, Costantino G, Mazzon E, Santagati S, Caputi AP, Thiemermann C. 2000. Effects of tempol, a membrane-permeable radical scavenger, in a rodent model of carrageenan-induced pleurisy. Eur J Pharmacol 390: 209-222.
48) Liu CM, Ma JQ, Lou Y. 2010. Chronic administration of troxerutin protects mouse kidney against D-galactose-induced oxidative DNA damage. Food Chem Toxicol 48: 2809-2817.
49) Aguila MB, Mandarim-De-Lacerda CA. 2003. Effects of chronic high fat diets on renal function and cortical structure in rats. Exp Toxicol Pathol 55: 187-195.
50) Coimbra TM, Janssen U, Grone HJ, Ostendorf T, Kunter U, Schmidt H, Brabant G, Floege J. 2000. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 57: 167-182.
51) Erbagci A, Yag IF, Sarica K, Bakir K. 2002. Predictive value of renal histological changes for postoperative renal function improvement in children with congenital ureteropelvic junction stenosis. Int J Urol 9: 279-284.
53) Hong SH, Suk KT, Choi SH, Lee JW, Sung HT, Kim CH, Kim EJ, Kim MJ, Han SH, Kim MY, Baik SK, Kim DJ, Lee GJ, Lee SK. 2013. Anti-oxidant and natural killer cell activity of Korean red ginseng (Panax ginseng) and urushiol (Rhus vernicifera Stokes) on non-alcoholic fatty liver disease of rat. Food Chem Toxicol 55: 586-591.
54) Kim GN, Lee JS, Song JH, Oh CH, Kwon YI, Jang HD. 2010. Heat processing decreases Amadori products and increases total phenolic content and antioxidant activity of Korean red ginseng. J Med Food 13: 1478-1484.
55) Oyagi A, Ogawa K, Kakino M, Hara H. 2010. Protective effects of a gastrointestinal agent containing Korean red ginseng on gastric ulcer models in mice. BMC Complement Altern Med 10: 45.
56) Joo KR, Shin HP, Cha JM, Nam S, Huh Y. 2009. Effect of Korean red ginseng on superoxide dismutase inhibitor-induced pancreatitis in rats: a histopathologic and immunohistochemical study. Pancreas 38: 661-666.
57) Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. 2006. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160: 1-40.
58) Cooke MS, Olinski R, Evans MD. 2006. Does measurement of oxidative damage to DNA have clinical significance? Clin Chim Acta 365: 30-49.
59) Yoshioka N, Nakashima H, Hosoda K, Eitaki Y, Shimada N, Omae K. 2008. Urinary excretion of an oxidative stress marker, 8-hydroxyguanine (8-OH-Gua), among nickel-cadmium battery workers. J Occup Health 50: 229-235.
60) Bonegio R, Lieberthal W. 2002. Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens 11: 301-308.
61) de Vries B, Matthijsen RA, van Bijnen AA, Wolfs TG, Buurman WA. 2003. Lysophosphatidic acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activation. Am J Pathol 163: 47-56.
62) Favreau F, Zhu XY, Krier JD, Lin J, Warner L, Textor SC, Lerman LO. 2010. Revascularization of swine renal artery stenosis improves renal function but not the changes in vascular structure. Kidney Int 78: 1110-1118.
63) Slater AF, Stefan C, Nobel I, van den Dobbelsteen DJ, Orrenius S. 1995. Signalling mechanisms and oxidative stress in apoptosis. Toxicol Lett 82-83: 149-153.
64) Lu J, Wu DM, Hu B, Cheng W, Zheng YL, Zhang ZF, Ye Q, Fan SH, Shan Q, Wang YJ. 2010. Chronic administration of troxerutin protects mouse brain against D-galactose-induced impairment of cholinergic system. Neurobiol Learn Mem 93: 157-164.
65) Yamamoto Y, Yamamoto H. 2012. Interaction of receptor for advanced glycation end products with advanced oxidation protein products induces podocyte injury. Kidney Int 82: 733-735.
66) Lotze MT, Tracey KJ. 2005. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5: 331-342.
67) Bae JS. 2012. Role of high mobility group box 1 in inflammatory disease: focus on sepsis. Arch Pharm Res 35: 1511-1523.